Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
N2OFF: Save Foods Received first order from a Peruvian Customer for its Eco-Friendly Solution for Fruits and Vegetables
-
Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation
-
Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation
-
DatChat to Participate in Upcoming EF Hutton Annual Global Conference on May 15th in New York City
-
Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million
-
Blank Rome Launches in Boston with Prominent 25-Attorney Corporate and Finance Team
-
Days Inns - Canada Earns Esteemed Franchisees' Choice Designation for Fourth Consecutive Year
-
ChildCare Education Institute Offers No-Cost Online Course on Establishing Trauma Informed Practices in Early Learning Environments
-
Alternus Clean Energy set to Acquire Over 80 MWp of Operating Solar PV across eight states in the U.S.
-
AITX’s RAD Receives Large RIO Expansion Order from Fortune 50 Client
-
SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level
-
One Stop Systems Announces Annual Meeting of Shareholders
-
NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
-
Novo Nordisk A/S - share repurchase programme
-
Calian Secures Contract Valued up to $90M for IT and Software Development Services with General Dynamics Mission Systems– Canada to Support Canadian Army
-
Motorsport Games Announces Sale of Traxion
-
Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024
-
Runway Growth Finance Corp. Announces Second Quarter Regular Dividend of $0.40 and $0.07 Supplemental Distribution
-
Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
-
Cepham’s Luteye Centers on Cellular Senescence to Protect Aging Eyes
-
Inuvo to Host First Quarter 2024 Financial Results Conference Call on Tuesday, May 7th at 4:15 P.M. ET
-
Voltus GmbH Selects Bridgeline's AI-Powered Site Search
-
SIPP Industries Announces Strategic Acquisition of Revenue Share in Calypso Pharmaceuticals to Bolster Position in Cannabis and Hemp Industries
-
IBN Announces From Lab to Launch Podcast Featuring Clene Inc. CEO Rob Etherington
-
GPS Capital Markets Director of HR is Honored as Recipient of Utah Business “HR Achievement Award”
-
Bayside Corporation Boosts Digital Presence Through Key Investment in Marketing Agency
-
Yield10 Bioscience Announces 1-for-24 Reverse Stock Split
-
Alpha Tau to Participate in May Investor Conferences
-
Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)
-
Real Brands Acquires Vapor Shark Assets
-
Earlyworks Co., Ltd. Reports Financial and Operational Performance for the Six Months Ended October 31, 2023
-
Voltus GmbH Selects Bridgeline's AI-Powered Site Search
-
Safe Harbor Financial Issues Statement on Cannabis Rescheduling
-
Kneat to Announce 2024 First Quarter Financial Results May 8, 2024
-
NewLake Capital Partners Issues Statement on Cannabis Being Rescheduled to Schedule III
-
ACAMS’ Assembly Europe Shares Innovative Strategies and Insights From More Than 90 Experts to Combat Emerging Financial Crime Threats
-
HII Declares Quarterly Dividend
-
Bionet America, Inc. Launches New Brio XVet Multiparameter Veterinary Monitors
-
SimpliFed Works with EmblemHealth to Support New Parents
-
Freddie Mac Announces First Quarter 2024 Financial Results
-
Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectives
-
Form 8.3 - Alpha Financial Markets Consulting plc
-
electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024
-
Radiation-Tolerant PolarFire® SoC FPGAs Offer Low Power, Zero Configuration Upsets, RISC-V Architecture for Space Applications
-
on|comms Selects Optiva BSS Platform to Connect Transitioning U.S. Veterans With Peer Mentors and Community Resources
-
Goodness Growth Provides CREAM & Fire Updates
-
Locafy Reports Fiscal Third Quarter 2024 Results
-
Creyon Bio and Cajal Neuroscience Announce Partnership to Develop Oligonucleotide-Based Medicines for Neurodegenerative Diseases
-
Goodness Growth Provides CREAM & Fire Updates
-
Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics
